Your browser doesn't support javascript.
loading
e-Lung Computed Tomography Biomarker Stratifies Patients at Risk of Idiopathic Pulmonary Fibrosis Progression in a 52-Week Clinical Trial.
Devaraj, Anand; Ottink, Finja; Rennison-Jones, Christian; Blé, François-Xavier; Joly, Olivier; Azim, Adnan; Gerry, Stephen; Harston, George; Ostridge, Kristoffer; George, Peter M.
Afiliação
  • Devaraj A; Royal Brompton Hospital, London, United Kingdom.
  • Ottink F; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Rennison-Jones C; Brainomix, Oxford, United Kingdom.
  • Blé FX; Brainomix, Oxford, United Kingdom.
  • Joly O; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
  • Azim A; Brainomix, Oxford, United Kingdom.
  • Gerry S; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
  • Harston G; Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Ostridge K; Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom.
  • George PM; Brainomix, Oxford, United Kingdom.
Am J Respir Crit Care Med ; 209(9): 1168-1169, 2024 05 01.
Article em En | MEDLINE | ID: mdl-38363798

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Tomografia Computadorizada por Raios X / Progressão da Doença / Fibrose Pulmonar Idiopática Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Tomografia Computadorizada por Raios X / Progressão da Doença / Fibrose Pulmonar Idiopática Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article